
Fonds de solidarité FTQ
Description
Fonds de solidarité FTQ is a prominent development capital fund based in Montréal, Canada, with a unique mandate to channel the savings of Quebecers into investments that foster economic growth and job creation within the province. Established by the Québec Federation of Labour (FTQ), its primary mission extends beyond mere financial returns, focusing on supporting the sustainable development of Quebec's economy, promoting innovation, and maintaining employment across various sectors.
The Fonds employs a comprehensive investment strategy, providing a range of financing solutions including equity, quasi-equity, and loans to small and medium-sized enterprises (SMEs). Their investment approach is characterized by a long-term perspective, often partnering with other financial institutions and private investors to support the growth and expansion of Quebec-based companies. They invest across diverse industries, from manufacturing and technology to services and natural resources, demonstrating a broad commitment to the provincial economic fabric.
As of November 30, 2023, the Fonds de solidarité FTQ managed net assets totaling $18.9 billion, making it a significant player in the Canadian investment landscape. Its substantial capital base enables it to make impactful investments, with typical first cheques ranging from $500,000 for smaller, innovative ventures to as much as $75 million for larger strategic initiatives. Over its history, the Fonds has supported more than 3,700 companies, contributing to the creation and maintenance of over 220,000 jobs throughout Quebec, underscoring its profound socio-economic impact.
Investor Profile
Fonds de solidarité FTQ has backed more than 91 startups, with 10 new investments in the last 12 months alone. The firm has led 14 rounds, about 15% of its total and boasts 78 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in Canada, United States, United Kingdom.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
- Led 5 rounds in the past year.
- Typical check size: $500K – $75M.
Stage Focus
- Series B (24%)
- Series Unknown (19%)
- Series A (19%)
- Series C (9%)
- Series D (9%)
- Private Equity (8%)
- Seed (7%)
- Post Ipo Equity (2%)
- Corporate Round (2%)
- Debt Financing (1%)
Country Focus
- Canada (86%)
- United States (10%)
- United Kingdom (2%)
- Israel (1%)
- France (1%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Software
- Medical
- Pharmaceutical
- Information Technology
- Biopharma
- Life Science
- Telecommunications
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.